Search company, investor...

OrphaMed

orphamed.com

Founded Year

2005

Stage

Series A | Alive

Total Raised

$19.1M

Last Raised

$19.1M | 11 yrs ago

About OrphaMed

OrphaMed is a biopharmaceutical company that develops medicines for the treatment of a family of genetic disorders called lysosomal storage diseases.

Headquarters Location

Goya 109 1º

2009,

Denmark

Missing: OrphaMed's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: OrphaMed's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

OrphaMed Frequently Asked Questions (FAQ)

  • When was OrphaMed founded?

    OrphaMed was founded in 2005.

  • What is OrphaMed's latest funding round?

    OrphaMed's latest funding round is Series A.

  • How much did OrphaMed raise?

    OrphaMed raised a total of $19.1M.

  • Who are the investors of OrphaMed?

    Investors of OrphaMed include Novo Holdings, Aescap Venture, Sunstone Capital, Clave, Suanfarma and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.